论文部分内容阅读
目的：探讨治疗晚期卵巢癌的方法。采用Ｓｅｌｄｉｎｇｅｒ法经一侧股动脉穿刺作超选择动脉插管化疗治疗晚期卵巢癌６１例（Ⅲ期５４例，Ⅳ期７例）分成二大组观察。结果：６１例患者有腹水５２例，胸水５例，治疗后腹水明显吸收４９例，占９４．２％，胸水吸收好转４例，占８０％。第一组４０例中有３３例获得再次手术时机，肿瘤体积比原来缩小１／２以上者３０例，占９０．９％。粘连松解３２例，其中３１例获得了手术成功。目前存活２４例，存活率达６０％。第二组２１例中存活３例，存活率为１４．３％。二组共存活２７例，总存活率为４４．３％。超选择动脉插管化疗治疗晚期卵巢癌是有效的。特别对首次手术困难者，先行动脉插管化疗为宜
Objective: To explore the treatment of advanced ovarian cancer. One hundred cases of advanced ovarian cancer (54 cases in stage III and 7 cases in stage IV) were divided into two groups according to the Seldinger method. Results: There were 52 cases of ascites and 5 cases of pleural effusion in 61 cases. After treatment, 49 cases (94.2%) were absorbed ascites, and 4 cases of pleural fluid absorption improved, accounting for 80%. In the first group of 40 cases, 33 cases received the opportunity for reoperation. The tumor volume was reduced by 1/2 or more from the original 30 cases, accounting for 90.9%. Thirty-two cases of adhesions were loosened, of which 31 cases had successful operation. At present, 24 cases survived and the survival rate reached 60%. In the second group of 21 cases, 3 survived and the survival rate was 14.3%. The two groups survived in 27 cases and the overall survival rate was 44.3%. Superselective arterial cannulation chemotherapy is effective for the treatment of advanced ovarian cancer. Especially for patients with first-time difficulty, it is advisable to perform arterial intubation chemotherapy